Drug-labels.com

Mar-Ramipril: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Facts
Strength:
1.25 mg, 2.5 mg, 5.0 mg, 10.0 mg, 15.0 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Mar-Ramipril

ABOUT THIS MEDICATION

What the medication is used for:

High Blood Pressure (Hypertension)

MAR-RAMIPRIL lowers high blood pressure. It can be used alone or together with a diuretic (“water pill”).

Following a Recent Heart Attack

MAR-RAMIPRIL reduces the effort required by your heart to pump blood. This is to compensate for the reduced pumping power that may have resulted from your heart attack. Ramipril has been shown to improve survival and reduce hospitalizations for heart failure in patients that are now clinically stable and recovering from recent heart attacks.

For the Management of Patients at Increased Risk of Cardiovascular Events

Your doctor has prescribed MAR-RAMIPRIL because:

  • You have coronary heart disease (such as chest pains or angina, or have had a heart attack in the past)
  • You had a stroke
  • You have peripheral vascular disease (poor blood circulation)
  • You have diabetes and at least one of the following physical conditions: high blood pressure, elevated total cholesterol levels, low high-density lipoprotein (HDL) levels, cigarette smoking or documented tiny amounts of albumin from your blood detected in your urine (microalbuminuria).

MAR-RAMIPRIL may lower the risk of heart attack, stroke, or death from heart disease in some patients who have a heart problem or poor blood circulation.

Managing your lifestyle

Keeping your blood pressure controlled

It takes more than just medication to reduce blood pressure. Discuss the risk factors, and how they apply to your lifestyle, with your doctor. You may have to modify some of your daily habits to keep your blood pressure down.

Exercise regularly. It will help to keep your weight down; make you feel more energetic and is a good way to deal with stress. If you are not exercising regularly, be sure to discuss a fitness plan with your doctor.

Remember, hypertension is a long-term disease without symptoms. Just because you feel fine does not mean you can stop taking your medication. If you stop, serious complications of the disease may occur. Therefore, you should continue to take MAR-RAMIPRIL regularly, as prescribed by your doctor.

The "lifestyle" part of your treatment is as important as your medication. By working as a team with your doctor, you can help reduce the risk of complications to maintain the style of life you are accustomed to.

  • Alcohol: Avoid alcoholic beverages until you have discussed their use with your doctor. Alcohol consumption may alter your blood pressure and/or increase the possibility of dizziness or fainting.

  • Diet: Generally, avoid fatty foods and food that is high in salt or cholesterol.
  • Smoking: Avoid it completely.

What it does:

MAR-RAMIPRIL is an angiotensin converting enzyme (ACE) inhibitor. You can recognize ACE inhibitors because their medicinal ingredient ends in ‘-PRIL’.

MAR-RAMIPRIL opens blood vessels to reduce blood pressure, just like the way opening a hose reduces water pressure.

This medicine does not cure your disease. It helps to control it. Therefore, it is important to continue taking MAR-RAMIPRIL regularly even if you feel fine.

When it should not be used:

Do not take MAR-RAMIPRIL if you:

  • Are allergic to ramipril or to any non-medicinal ingredient in the formulation.
  • Have experienced an allergic reaction (angioedema) with swelling of the hands, feet, or ankles, face, lips, tongue, throat, or sudden difficulty breathing or swallowing, to any ACE inhibitor or without a known cause. Be sure to tell your doctor, nurse, or pharmacist that this has happened to you.
  • Have been diagnosed with hereditary angioedema: an increased risk of getting an allergic reaction that is passed down through families. This can be triggered by different factors, such as surgery, flu, or dental procedures.
  • Are pregnant or intend to become pregnant. Taking MAR-RAMIPRIL during pregnancy can cause injury and even death to your baby.
  • Are breastfeeding. MAR-RAMIPRIL passes into breast milk.
  • Are taking ENTRESTO® (sacubitril/valsartan), due to the increased risk of serious allergic reaction which causes swelling of the face or throat (angioedema) when taken with MAR-RAMIPRIL. You must wait at least 36 hours after your last dose of sacubitril/valsartan before taking MAR-RAMIPRIL

IMPORTANT: PLEASE READ

Serious Warnings and Precautions – Pregnancy

MAR-RAMIPRIL should not be used during pregnancy. If you discover that you are pregnant while taking MAR-RAMIPRIL, stop the medication and please contact your doctor, nurse, or pharmacist as soon as possible.

  • Have narrowing of the arteries to one or both kidneys (renal artery stenosis).
  • Have hypotension (low blood pressure).
  • Are on dialysis or LDL apheresis (a treatment to remove LDL cholesterol from the blood).
  • Are already taking a blood pressure-lowering medicine containing aliskiren (such as RASILEZ®) and you have one of the following conditions:

    • diabetes
    • kidney disease
    • high potassium levels
    • heart failure combined with low blood pressure
  • Are taking an angiotensin receptor blocker (ARB), another medicine to treat your high blood pressure, or another ACE inhibitor and have one of the following conditions:

    • diabetes with end organ damage
    • kidney disease
    • high potassium levels
    • heart failure combined with low blood pressure

You can recognize an ARB because its medicinal ingredient ends in “-SARTAN”.

What the medicinal ingredient is:

Ramipril

What the nonmedicinal ingredients are:

Pregelatinized Starch

The capsule shell contains the non-medical ingredients:

MAR-Ramipril 1.25 mg: contains gelatin, methyl paraben, propyl paraben, iron oxide yellow and titanium dioxide.

MAR-Ramipril 2.5 mg: contains gelatin, methyl paraben, propyl paraben, carmoisine, ponceau 4R, sunset yellow and titanium dioxide.

MAR-Ramipril 5 mg: contains gelatin, methyl paraben, propyl paraben, brilliant blue, carmoisine, ponceau 4R, and titanium dioxide.

MAR-Ramipril 10 mg: contains gelatin, methyl paraben, propyl paraben, brilliant blue, carmoisine, erythrosine, and titanium dioxide.

MAR-Ramipril 15 mg: contains gelatin, methyl paraben, propyl paraben, brilliant blue, phloxine, iron oxide black, and titanium dioxide.

MAR-Ramipril is available in hard gelatin capsules in the following potencies:

1.25 mg: Yellow/white coloured hard gelatin capsules, size 4; with ‘1.25’ imprinted in black on body, filled with a homogenous white to off white powder.

2.5 mg: Orange/white coloured hard gelatin capsules, size 4; with ‘2.5’ imprinted in black on body, filled with a homogenous white to off white powder.

5 mg: Maroon/white coloured hard gelatin capsules, size 4; with ‘5’ imprinted in black on body, filled with a homogenous white to off white powder.

10 mg: Blue/white coloured hard gelatin capsules, size 4; with ‘10’ imprinted in black on body, filled with a homogenous white to off white powder.

15 mg: Blue / grey colored size ‘3’ hard gelatin capsules, with “15” imprinted in black on body, filled with white to off-white blend.

What dosage forms it comes in:

Capsules 1.25 mg, 2.5 mg, 5 mg, 10 mg and 15 mg.

WARNINGS AND PRECAUTIONS

BEFORE you use MAR-RAMIPRIL talk to your doctor, nurse, or pharmacist if you:

  • Are allergic to any drug used to lower blood pressure.
  • Have recently received or are planning to get allergy shots for bee or wasp stings.
  • Have narrowing of an artery or a heart valve.
  • Have had a heart attack or stroke.
  • Have diabetes.
  • Have liver disease. Your doctor should take blood tests to measure your liver function before you start taking MAR-RAMIPRIL and occasionally throughout your treatment.
  • Have kidney disease. Your doctor should take regular blood tests to measure your kidney function and the levels of potassium in your blood.
  • Have Raynaud' s phenomenon which is a condition resulting from poor circulation in the extremities (i.e., fingers and toes). It may begin or get worse.
  • Have diabetes, liver or kidney disease.
  • Are on dialysis or LDL apheresis (a treatment to remove LDL cholesterol from the blood).
  • Are dehydrated or suffer from excessive vomiting, diarrhea, or sweating.
  • Are taking a salt substitute that contains potassium, potassium supplements, a potassium-sparing diuretic (a specific kind of “water pill”), or other medicinal products that may increase potassium. Use of MAR-RAMIPRIL with these medicines is not recommended.
  • Are on a low-salt diet.
  • Are receiving gold (sodium aurothiomalate) injections.
  • Are less than 18 years old.
  • Are taking a medicine that contains aliskiren, such as RASILEZ®, used to lower high blood pressure. The combination with MAR-RAMIPRIL is not recommended.
  • Are taking an angiotensin receptor blocker (ARB). You

    can recognize an ARB because its medicinal ingredient ends in “-SARTAN”. The combination with MAR-RAMIPRIL is not recommended.

IMPORTANT: PLEASE READ

If you think you, or a person you are caring for, have taken too much MAR-RAMIPRIL, contact a healthcare professional, hospital emergency department, regional poison control centre

or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms.

  • Are taking drugs such as:

    • Temsirolimus and everolimus (used to treat cancer),
    • Sirolimus (used to prevent organ rejection after a transplant),
    • Sitagliptin or other gliptins (used to treat Type II diabetes),
    • A neutral endopeptidase inhibitor

Taking ACE inhibitors, such as MAR-RAMIPRIL, with these types of drugs may increase your chances of having an allergic reaction (angioedema). You may become sensitive to the sun while taking MAR-RAMIPRIL. Exposure to sunlight should be minimized until you know how you respond.

If you are going to have surgery and will be given an anesthetic, be sure to tell your doctor or dentist that you are taking MAR-RAMIPRIL.

Driving and using machines

Before you perform tasks which may require special attention, wait until you know how you respond to MAR-RAMIPRIL. Dizziness, light-headedness, or fainting can especially occur after the first dose and when the dose is increased.

IINTERACTION WITH THIS MEDICATION

As with most medicines, interactions with other drugs are possible. Tell your doctor, nurse, or pharmacist about all the medicines you take, including drugs prescribed by other doctors, vitamins, minerals, natural supplements, or alternative medicines.

The following may interact with MAR-RAMIPRIL:

  • Agents increasing serum potassium, such as a salt substitute that contains potassium, potassium supplements, a potassium-sparing diuretic (a specific kind of “water pill”), or other medicinal products that may increase potassium. Use of MAR-RAMIPRIL with these medicines is not recommended.
  • Alcohol
  • Allopurinol used to treat gout.
  • Antidiabetic drugs, including insulin and oral medicines, such as gliptins (e.g. sitagliptin).
  • Lithium used to treat bipolar disease.
  • Gold for the treatment of rheumatoid arthritis.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs), used to reduce pain and swelling. Examples include ibuprofen, naproxen, and celecoxib.
  • Blood pressure lowering drugs, including diuretics (“water pills”), aliskiren-containing products (e.g. RASILEZ®), or angiotensin receptor blockers (ARBs).
  • Nitrates used to treat angina (chest pain)

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

  • Acetylsalicylic acid (aspirin)
  • Heparin used to prevent and treat blood clots
  • Immunosuppressants used to lower the body’s ability to reject a transplanted organ
  • Corticosteroids used to treat joint pain and swelling or for other conditions.
  • Procainamide used to treat irregular heartbeat
  • Cytostatic medicines used to treat certain types of cancer
  • mTOR inhibitors used to lower the body’s ability to reject a transplant (e.g. sirolimus) or to treat certain types of cancer (e.g. tersirolimus, everolimus)
  • Neutral endopeptidase (NEP) inhibitors.

PROPER USE OF THIS MEDICATION

Take MAR-RAMIPRIL exactly as prescribed. It is recommended to take your dose at about the same time every day.

Capsules should be swallowed whole. DO NOT open, divide, crush or chew the capsules.

Usual adult dose:

High Blood Pressure: The recommended initial dosage of MAR-RAMIPRIL is 2.5 mg once daily. Your doctor will determine the appropriate dosage.

Following a Recent Heart Attack: The recommended initial dosage of MAR-RAMIPRIL is 2.5 mg given twice a day in the morning and in the evening for patients with clinical signs of heart failure (a condition in which the heart has difficulty pumping enough blood to the body's other organs). Treatment should be started under close medical supervision.

For patients taking diuretics (“water pills”) or with impaired kidney function: The recommended initial dosage of MAR-RAMIPRIL is 1.25 mg daily.

Management of Patients at Increased Risk of Cardiovascular Events: The recommended initial dosage of MAR-RAMIPRIL is 2.5 mg once daily. Your doctor will determine the appropriate dosage.

Overdose:

Missed Dose:

If you have forgotten to take your dose during the day, carry on with the next one at the usual time. Do not double dose.

IMPORTANT: PLEASE READ

Side effects may include:

  • Dizziness, difficulty in maintaining your balance while standing
  • drowsiness, fatigue, weakness
  • cough, nasal or sinus congestion, swollen lymph nodes, bronchitis, aggravated asthma
  • rash, itching, flushing, inflammation of the eye (pink eye), skin inflammation or red skin, burning sensation, inflammation of the mouth or tongue
  • headache
  • abdominal pain
  • sad mood, difficulty with sleep, restlessness, attention disturbances
  • loss of hair
  • taste modifications or loss of taste, vision or hearing modifications
  • impotence/reduced libido, breast enlargement in males

If any of these affects you severely, tell your doctor, nurse or pharmacist.

MAR-RAMIPRIL can cause abnormal blood test results. Your doctor will decide when to perform blood tests and will interpret the results.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM

Frequency / Side Effect / SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Only if severeIn all cases
C o mmo n

Low blood pressure:

Dizziness, fainting, lightheadedness

May occur when you go from lying or sitting to standing up.

✓

Increased levels of potassium in the blood

Irregular heartbeat, muscle weakness and generally feeling unwell.

✓
U nc o mmo n

Allergic reaction:

Rash, hives, swelling of the face, arms and legs, lips, tongue or throat, difficulty swallowing or breathing.

✓
Frequency / Side Effect / SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Only if severeIn all cases
U nc o mmo nKidney Disorder: change in frequency of urination, nausea, vomiting, swelling of extremities, fatigue.✓

Liver Disorder:

yellowing of the skin or eyes, dark urine, abdominal pain, nausea, vomiting, loss of appetite

✓

Electrolyte Imbalance:

weakness, drowsiness, muscle pain or cramps, irregular heartbeat

✓
R a r e

Decreased Platelets:

bruising, bleeding, fatigue and weakness

✓

Decreased White Blood Cells:

infections, fatigue, fever, aches, pains, and flu-like symptoms

✓
Heart Attack: chest pain and/or discomfort, pain in the jaw shoulders, arm and/or back shortness of breath, sweating, lightheadedness, nausea✓
Ra r e

Cerebro-vascular accident/ Stroke:

weakness, trouble speaking, trouble seeing, headache, dizziness

✓

Intestinal Angioedema:

abdominal pain (with or without nausea or vomiting)

✓

This is not a complete list of side effects. For any unexpected effects while taking MAR-RAMIPRIL, contact your doctor, nurse or pharmacist.

HOW TO STORE IT

Store MAR-Ramipril in original container at room temperature (15- 30ºC). Protect from light and moisture, and not beyond the date indicated on the container.

IMPORTANT: PLEASE READ

Keep out of reach and sight of children.

Reporting side effects

You can report any suspected side effects associated with the use of health products to Health Canada by:
  • Visiting the Web page on Adverse Reaction Reporting

    (canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or

  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice

IF you want more information about MAR-RAMIPRIL

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes the Patient Medication Information by visiting the Health Canada Drug Product Database website (Drug Product Database: Access the database); the manufacturer’s website www.marcanpharma.com, or by calling 1-855-627-2261.

IMPORTANT: PLEASE READ

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02420457

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Mar-Ramipril

Rx or OTC
Prescription (Rx)?
DIN 02420457, 02420465, 02420473, 02420481, 02420503
Schedule(s) PRESCRIPTION
Active ingredient(s) Ramipril
Dosage form(s) Capsule
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C09 Agents acting on the renin-angiotensin system
      1. C09A ACE inhibitors, plain
        1. C09AA ACE inhibitors, plain
          1. C09AA05 Ramipril
Company MARCAN PHARMACEUTICALS INC
Strengths and forms
DIN Strength Dosage form(s) Current status
02420457 1.25 MG Capsule Dormant June 26, 2020
02420465 2.5 MG Capsule Marketed January 9, 2015
02420473 5.0 MG Capsule Marketed January 9, 2015
02420481 10.0 MG Capsule Marketed January 9, 2015
02420503 15.0 MG Capsule Marketed September 10, 2014

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.